(Contract up to December 2012)
The NICB (
www.nicb.ie) is a multidisciplinary centre of research in fundamental and applied Cellular Biotechnology, Molecular Cell Biology, Ocular diseases and Biological Chemistry. It includes a multidisciplinary team of Cell and Molecular Biologists, Biotechnologists, Chemists and Computer Scientists. The NICB has combined the variety of expertise of its researchers to develop targeted research programmes in key areas relating to identification of new therapeutic targets and diagnostic methods for disease, in particular for cancer. Molecular Therapeutics for Cancer, Ireland (MTCI,
www.mtci.ie) is a Strategic Research Cluster, led by Prof John Crown, which aims to develop new targeted therapies for cancer.
Role
As part of an ongoing Health Research Board (HRB) funded research programme a Postdoctoral Researcher position is now available in Dublin City University within the NICB, under the supervision of Professor John Crown and Dr Norma O’Donovan. The successful candidate will join a multi-disciplinary team working with academic scientists, clinicians and industrial partners.
The postdoctoral research project will involve:
• Examining genes/proteins that may be involved in response or resistance to HER2 antagonists in breast cancer.
• Using tumour samples, serum samples and cell line models of resistance to identify markers of resistance using transcriptomic and proteomic techniques.
• Validating gene/protein targets and develop strategies to overcome resistance.
Qualifications & Experience
The ideal candidate will have PhD in cancer biology, or related discipline, and have experience of immunohistochemistry, proteomic and/or genomic techniques, cell culture and cell signalling. Evidence of excellent scientific communication skills (both written and oral) is highly desirable.
Further information and application forms are available on the DCU web site:
http://www.dcu.ie/vacancies/index.shtml and from the Human Resources Department, Dublin City University, Dublin 9. Tel: +353 1 700 5149; Fax: +353 1 700 5500
Email:
[email protected]
